| Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer C Germain, S Gnjatic, F Tamzalit, S Knockaert, R Remark, J Goc, ... American journal of respiratory and critical care medicine 189 (7), 832-844, 2014 | 780 | 2014 |
| Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells J Goc, C Germain, TKD Vo-Bourgais, A Lupo, C Klein, S Knockaert, ... Cancer research 74 (3), 705-715, 2014 | 651 | 2014 |
| Tertiary lymphoid structures in cancer and beyond MC Dieu-Nosjean, J Goc, NA Giraldo, C Sautès-Fridman, WH Fridman Trends in immunology 35 (11), 571-580, 2014 | 589 | 2014 |
| Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin R Remark, M Alifano, I Cremer, A Lupo, MC Dieu-Nosjean, M Riquet, ... Clinical Cancer Research 19 (15), 4079-4091, 2013 | 387 | 2013 |
| Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer L de Chaisemartin, J Goc, D Damotte, P Validire, P Magdeleinat, ... Cancer research 71 (20), 6391-6399, 2011 | 356 | 2011 |
| TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma J Biton, A Mansuet-Lupo, N Pécuchet, M Alifano, H Ouakrim, J Arrondeau, ... Clinical Cancer Research 24 (22), 5710-5723, 2018 | 319 | 2018 |
| Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 L Zhou, C Chu, F Teng, NJ Bessman, J Goc, EK Santosa, GG Putzel, ... Nature 568 (7752), 405-409, 2019 | 267 | 2019 |
| Calreticulin expression in human Non–Small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis J Fucikova, E Becht, K Iribarren, J Goc, R Remark, D Damotte, M Alifano, ... Cancer research 76 (7), 1746-1756, 2016 | 196 | 2016 |
| Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients I Truxova, L Kasikova, M Hensler, P Skapa, J Laco, L Pecen, L Belicova, ... Journal for ImmunoTherapy of Cancer 6, 1-13, 2018 | 187 | 2018 |
| ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut M Lyu, H Suzuki, L Kang, F Gaspal, W Zhou, J Goc, L Zhou, J Zhou, ... Nature 610 (7933), 744-751, 2022 | 185 | 2022 |
| Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer M Alifano, A Mansuet-Lupo, F Lococo, N Roche, A Bobbio, E Canny, ... PloS one 9 (9), e106914, 2014 | 185 | 2014 |
| Lymphoid-tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism TC Fung, NJ Bessman, MR Hepworth, N Kumar, N Shibata, D Kobuley, ... Immunity 44 (3), 634-646, 2016 | 164 | 2016 |
| Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer J Goc, M Lv, NJ Bessman, AL Flamar, S Sahota, H Suzuki, F Teng, ... Cell 184 (19), 5015-5030. e16, 2021 | 148 | 2021 |
| Characteristics of tertiary lymphoid structures in primary cancers J Goc, WH Fridman, C Sautès-Fridman, MC Dieu-Nosjean Oncoimmunology 2 (12), e26836, 2013 | 140 | 2013 |
| TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non–small cell lung cancer S Chatterjee, L Crozet, D Damotte, K Iribarren, C Schramm, M Alifano, ... Cancer research 74 (18), 5008-5018, 2014 | 117 | 2014 |
| The immune microenvironment: a major player in human cancers WH Fridman, R Remark, J Goc, NA Giraldo, E Becht, SA Hammond, ... International archives of allergy and immunology 164 (1), 13-26, 2014 | 96 | 2014 |
| A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut F Teng, J Goc, L Zhou, C Chu, MA Shah, G Eberl, GF Sonnenberg Science immunology 4 (40), eaax1215, 2019 | 93 | 2019 |
| Impaired tumor-infiltrating T cells in patients with chronic obstructive pulmonary disease impact lung cancer response to PD-1 blockade J Biton, H Ouakrim, A Dechartres, M Alifano, A Mansuet-Lupo, H Si, ... American Journal of Respiratory and Critical Care Medicine 198 (7), 928-940, 2018 | 91 | 2018 |
| Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions J Russick, PE Joubert, M Gillard-Bocquet, C Torset, M Meylan, F Petitprez, ... Journal for immunotherapy of cancer 8 (2), e001054, 2020 | 90 | 2020 |
| Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients R Remark, A Lupo, M Alifano, J Biton, H Ouakrim, A Stefani, I Cremer, ... Oncoimmunology 5 (12), e1255394, 2016 | 87 | 2016 |
Marco AlifanoProfessor of Thoracic Surgery, Paris Center University Hospitals, Paris Descartes UniversityEmail confirmado em cch.aphp.fr